Physician

Larry D. Mckenzie, DO

According to 2025 Medicare claims, Larry Mckenzie, DO (NPI: 1003875212) practices pain management in the Tulsa, OK market, with the plurality of this provider's patient population coming from Tulsa, OK. This provider's primary affiliated billing organization is ACCESS PAIN SOLUTIONS (NPI: 1740535368; TIN: 460607629) and primary practice location at 74146-5222. Mckenzie is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616), participating under the MSSP model.

Mckenzie's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 959 traditional Medicare patients, billed 16,707 HCPCS/CPT codes, and received $683,734 in Medicare payments. The top billing code was G0482 (Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms). Part D data shows 11,239 prescription claims across 823 beneficiaries totaling $570,563 in drug costs, led by Belbuca (Buprenorphine Hcl). 2020 DME data shows 24 claims. Open Payments data shows 20 records totaling $489. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $29,006 to $683,734. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $81,964 to $570,563. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	165	577	$29,006
2016	179	568	$28,575
2017	256	962	$50,779
2018	344	1,095	$70,186
2019	375	1,230	$81,205
2020	359	1,242	$87,126
2021	434	2,508	$127,106
2022	786	11,836	$512,072
2023	947	15,683	$665,251
2024	959	16,707	$683,734

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	108	881	$81,964
2016	119	1,127	$116,163
2017	171	1,343	$131,523
2018	253	1,966	$119,419
2019	285	2,422	$150,226
2020	290	2,540	$97,254
2021	533	3,400	$225,334
2022	679	8,642	$540,141
2023	704	9,736	$639,319
2024	823	11,239	$570,563

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$20,007
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	24	$3,934
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0482	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms	578	1,172	$193
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	490	841	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	743	2,131	$61
80307	Testing for presence of drug, by chemistry analyzers	807	2,689	$60
96127	Assessment of emotional or behavioral problems	787	2,414	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Belbuca	Buprenorphine Hcl	148	4,440	$115,515
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	2,979	87,069	$84,556
Buprenorphine	Buprenorphine	262	7,315	$75,401
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	1,673	48,654	$52,708
Xtampza Er	Oxycodone Myristate	68	1,981	$33,910

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$489	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Larry D. Mckenzie, DO?

Tedicare shows public-source Medicare data for Larry D. Mckenzie, DO (NPI 1003875212), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Larry D. Mckenzie, DO have ACO affiliation data?

Larry D. Mckenzie, DO is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616).

What billing organization is linked to Larry D. Mckenzie, DO?

Larry D. Mckenzie, DO is linked to ACCESS PAIN SOLUTIONS (billing NPI 1740535368) in the available physician profile data.

Does Larry D. Mckenzie, DO have Open Payments data?

Larry D. Mckenzie, DO has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.